Navigation Links
GeneGo and OmicSoft Announce Integration
Date:5/12/2009

ST. JOSEPH, Mich., May 12 /PRNewswire/ -- GeneGo, Inc., the leading provider of pathway data mining & analysis solutions, and OmicSoft Corporation, the premiere visualization and analysis software for the interpretation of high dimensional data, today announced the integration of the MetaCore(TM) pathway analysis platform with Array Studio.

"Array Studio is a powerful analysis platform and we have mutual customers that this integration will benefit," said Julie Bryant, VP of Business Development at GeneGo. "One of the key parts of this integration will be for users of Array Studio to easily access GeneGo's wealth of canonical pathway maps, in order to enhance their data analysis and hypothesis testing workflow."

"MetaCore integration with Array Studio will have an immediate impact for some of our mutual clients, taking the analysis results generated by Array Studio and moving it to the next level with GeneGo's pathway analysis tools," said Jack Liu, President at OmicSoft. "GeneGo's flexibility and collaborative thinking has made this a smooth integration, and we look forward to working more with them in the future."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.3(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.3(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.

About Array Studio and OmicSoft Corporation

OmicSoft Corporation focuses on biomarker data management, visualization, and analysis. To achieve this, OmicSoft has designed software that is easy to use by the bench scientists, but powerful enough to be used by the bioinformatician or statistician. OmicSoft's products are designed with the influence of all three groups, and thus are fast, powerful, and easy to use. OmicSoft currently markets Array Studio for analysis and Array Server as an enterprise solution.

Array Studio is a software package which provides state of the art statistics and visualization for the analysis of high dimensional quantification data (e.g. Microarray or Taqman data), genotype data (e.g. SNP data, Copy Number data). The software is designed for ease of use so that biologists can function at near the level of informatics specialists, providing the fastest, easiest, and most powerful solution on the market. Array Studio includes support for all popular microarray platforms (Affymetrix, Agilent, Illumina, etc.), as well as support for SNP/Genotype platforms (Affymetrix, Illumina, etc.), and Copy Number platforms (Affymetrix, Illumina, Agilent). It provides analysis modules for Exon/gene arrays, as well as an industry-leading Taqman import and normalization module. With over 40 unique, fully interactive, and highly customizable views, users can create exciting presentations through the program's seamless integration with Excel and PowerPoint.

For more information, please visit the company's website at www.omicsoft.com


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals
2. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
3. Elan Pharmaceuticals Joins GeneGos MetaTox Consortium
4. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
5. GeneGos First Customer in Hong Kong; The Chinese University of Hong Kong
6. KineMed Licenses GeneGos MetaCore
7. A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: